NXTC
Price
$1.80
Change
+$0.05 (+2.86%)
Updated
Jun 23, 04:06 PM (EDT)
Capitalization
6.3M
37 days until earnings call
Intraday BUY SELL Signals
OCS
Price
$11.96
Change
+$0.29 (+2.49%)
Updated
Jun 23, 04:13 PM (EDT)
Capitalization
704.12M
44 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

NXTC vs OCS

NXTC vs OCS Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
NXTC vs. OCS commentary
Jun 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NXTC is a Hold and OCS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 23, 2026
Stock price -- (NXTC: $1.75 vs. OCS: $11.66)
Brand notoriety: NXTC and OCS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NXTC: 166% vs. OCS: 54%
Market capitalization -- NXTC: $6.3M vs. OCS: $704.12M
NXTC [@Biotechnology] is valued at $6.3M. OCS’s [@Biotechnology] market capitalization is $704.12M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NXTC’s FA Score shows that 1 FA rating(s) are green whileOCS’s FA Score has 0 green FA rating(s).

  • NXTC’s FA Score: 1 green, 4 red.
  • OCS’s FA Score: 0 green, 5 red.
According to our system of comparison, NXTC is a better buy in the long-term than OCS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NXTC’s TA Score shows that 4 TA indicator(s) are bullish while OCS’s TA Score has 6 bullish TA indicator(s).

  • NXTC’s TA Score: 4 bullish, 4 bearish.
  • OCS’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, OCS is a better buy in the short-term than NXTC.

Price Growth

NXTC (@Biotechnology) experienced а -11.87% price change this week, while OCS (@Biotechnology) price change was +0.43% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.01%. For the same industry, the average monthly price growth was +3.19%, and the average quarterly price growth was +1969.85%.

Reported Earning Dates

NXTC is expected to report earnings on Jul 30, 2026.

OCS is expected to report earnings on Aug 06, 2026.

Industries' Descriptions

@Biotechnology (+7.01% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OCS($704M) has a higher market cap than NXTC($6.3M). OCS YTD gains are higher at: -41.612 vs. NXTC (-87.703). NXTC has higher annual earnings (EBITDA): -54.29M vs. OCS (-93.55M). OCS has more cash in the bank: 222M vs. NXTC (29.7M). OCS has less debt than NXTC: OCS (2.25M) vs NXTC (3.88M). NXTC (0) and OCS (0) have equivalent revenues.
NXTCOCSNXTC / OCS
Capitalization6.3M704M1%
EBITDA-54.29M-93.55M58%
Gain YTD-87.703-41.612211%
P/E RatioN/A63.08-
Revenue00-
Total Cash29.7M222M13%
Total Debt3.88M2.25M173%
FUNDAMENTALS RATINGS
NXTC: Fundamental Ratings
NXTC
OUTLOOK RATING
1..100
52
VALUATION
overvalued / fair valued / undervalued
1..100
7
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
98
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
45

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NXTCOCS
RSI
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
57%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
59%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
58%
MACD
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
62%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
55%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
51%
Advances
ODDS (%)
N/A
Bullish Trend 9 days ago
73%
Declines
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 6 days ago
62%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
58%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
53%
View a ticker or compare two or three
Interact to see
Advertisement
NXTC
Daily Signal:
Gain/Loss:
OCS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DSS0.600.06
+11.19%
DSS
RIGL35.712.80
+8.51%
Rigel Pharmaceuticals Inc
GPCR45.591.08
+2.43%
Structure Therapeutics
LH254.43-1.39
-0.54%
Laboratory Corp
WSBK12.90-0.31
-2.31%
Winchester Bancorp Inc

NXTC and

Correlation & Price change

A.I.dvisor indicates that over the last year, NXTC has been loosely correlated with OCS. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if NXTC jumps, then OCS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NXTC
1D Price
Change %
NXTC100%
-13.61%
OCS - NXTC
38%
Loosely correlated
+3.92%
CYTK - NXTC
37%
Loosely correlated
+0.51%
NUVL - NXTC
35%
Loosely correlated
-0.02%
ORMP - NXTC
33%
Poorly correlated
+3.09%
GOSS - NXTC
32%
Poorly correlated
-2.26%
More

OCS and

Correlation & Price change

A.I.dvisor indicates that over the last year, OCS has been loosely correlated with NXTC. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if OCS jumps, then NXTC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OCS
1D Price
Change %
OCS100%
+3.92%
NXTC - OCS
38%
Loosely correlated
-13.61%
FTH - OCS
32%
Poorly correlated
+30.75%
NUVL - OCS
31%
Poorly correlated
-0.02%
GRI - OCS
30%
Poorly correlated
-0.53%
JSPR - OCS
29%
Poorly correlated
+12.94%
More